[HTML][HTML] Review of early immune response to SARS-CoV-2 vaccination among patients with CKD
EJ Carr, A Kronbichler, M Graham-Brown… - Kidney international …, 2021 - Elsevier
The effects of the coronavirus disease-2019 (COVID-19) pandemic, particularly among
those with chronic kidney disease (CKD), who commonly have defects in humoral and …
those with chronic kidney disease (CKD), who commonly have defects in humoral and …
The COVID-19 pandemic and ANCA-associated vasculitis–reports from the EUVAS meeting and EUVAS education forum
A Kronbichler, D Geetha, RM Smith, AC Egan… - Autoimmunity …, 2021 - Elsevier
Abstract The Coronavirus Disease 2019 (COVID-19) pandemic influenced the management
of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. A paucity …
of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. A paucity …
COVID-19 vaccination followed by activation of glomerular diseases: does association equal causation?
NL Li, PT Coates, BH Rovin - Kidney International, 2021 - kidney-international.org
To date,> 4 billion doses of the various severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) vaccines have been administered worldwide in response to the coronavirus …
(SARS-CoV-2) vaccines have been administered worldwide in response to the coronavirus …
Antigen specific humoral and cellular immunity following SARS-CoV-2 vaccination in ANCA-associated vasculitis patients receiving B-cell depleting therapy
PK Marty, VP Van Keulen, CL Erskine, M Shah… - Frontiers in …, 2022 - frontiersin.org
Humoral vaccine responses are known to be suboptimal in patients receiving B-cell targeted
therapy, and little is known about vaccine induced T-cell immunity in these patients. In this …
therapy, and little is known about vaccine induced T-cell immunity in these patients. In this …
Risk factors associated with poor response to COVID-19 vaccination in kidney transplant recipients
Y Azzi, H Raees, T Wang, L Cleare… - Kidney …, 2021 - kidney-international.org
To the editor: The case fatality ratio of coronavirus disease 2019 (COVID-19) in kidney
transplant recipients is between 10% and 30%, 1, 2 underscoring the importance of …
transplant recipients is between 10% and 30%, 1, 2 underscoring the importance of …
COVID-19 vaccination in cancer patients: A review article
R Mekkawi, BA Elkattan, A Shablak, M Bakr… - Cancer …, 2022 - journals.sagepub.com
Coronavirus disease 2019 (COVID-19) infection is caused by severe acute respiratory
syndrome coronavirus 2. Adults with cancer are immunocompromised due to several causes …
syndrome coronavirus 2. Adults with cancer are immunocompromised due to several causes …
Impact of rituximab on humoral response to COVID-19 booster vaccine and antibody kinetics in patients with anti–neutrophil cytoplasmic antibody vasculitis
microscopic polyangiitis phenotype and received rituximab as induction therapy, whereas all
patents were on rituximab maintenance. Only 1 patient was on steroid maintenance therapy …
patents were on rituximab maintenance. Only 1 patient was on steroid maintenance therapy …
Anti-MDA5 amyopathic dermatomyositis—a diagnostic and therapeutic challenge
A Bobirca, C Alexandru, AE Musetescu, F Bobirca… - Life, 2022 - mdpi.com
Clinically amyopathic Dermatomyositis (CADM) is a rare subtype of idiopathic inflammatory
myositis, associated with no muscular manifestations, which is more frequent in Asian …
myositis, associated with no muscular manifestations, which is more frequent in Asian …
[HTML][HTML] Factors associated with immune responses to SARS-CoV-2 vaccination in autoimmune disease individuals
E Anderson, M Powell, E Yang, A Kar, TM Leung… - JCI …, 2024 - Am Soc Clin Investig
JCI Insight - Factors associated with immune responses to SARS-CoV-2 vaccination in
autoimmune disease individuals Go to The Journal of Clinical Investigation About Editors …
autoimmune disease individuals Go to The Journal of Clinical Investigation About Editors …
[HTML][HTML] SARS-CoV-2 vaccine response in patients with antineutrophil cytoplasmic autoantibody–associated vasculitis
L Floyd, ME Elsayed, T Seibt… - Kidney International …, 2022 - Elsevier
Results A total of 159 patients were included with a mean (SD) age of 65 (14) years. The
average time from diagnosis of AAV was 7 years (±6). Most patients had AAV with …
average time from diagnosis of AAV was 7 years (±6). Most patients had AAV with …